Journal of Molecular Structure, Год журнала: 2024, Номер unknown, С. 141239 - 141239
Опубликована: Дек. 1, 2024
Язык: Английский
Journal of Molecular Structure, Год журнала: 2024, Номер unknown, С. 141239 - 141239
Опубликована: Дек. 1, 2024
Язык: Английский
RSC Advances, Год журнала: 2025, Номер 15(10), С. 7571 - 7608
Опубликована: Янв. 1, 2025
Benzimidazole, a fused bicyclic compound with benzene and pentacyclic 1,3-diazole moeities, has simple aromatic heterocyclic structure. The moiety become an indispensable anchor for the development of new pharmacologically active products, yielded several therapeutic agents anticancer, antihypertensive, antimicrobial, antifungal antiulcer effects. Benzimidazoles, as synthetically feasible pharmacophoric synthons, have been relentlessly pursued preparation analogues derivatives, they successfully developed into some most sought-after vital pharmacophores drug discovery. use varied substituents differing patterns around benzimidazole nucleus provided wide spectrum biological activities. In addition, constitutes building block production drugs, candidates, chemical entities, lead molecules. importance this bioactivity, e.g., antibacterial, antitubercular, antidiabetic, antifungal, anti-inflammatory, analgesic, antioxidant, antihistaminic, antimalarial activity, led us to take note provide overview synthetic approaches various derivatives together their actions. This review is projected further assist in design benzimidazole-based compounds optimized products towards drug-development strategies.
Язык: Английский
Процитировано
0Journal of Molecular Structure, Год журнала: 2025, Номер unknown, С. 142216 - 142216
Опубликована: Март 1, 2025
Язык: Английский
Процитировано
0International Journal of Biological Macromolecules, Год журнала: 2024, Номер 285, С. 138250 - 138250
Опубликована: Дек. 3, 2024
Язык: Английский
Процитировано
0Journal of Molecular Structure, Год журнала: 2024, Номер unknown, С. 141239 - 141239
Опубликована: Дек. 1, 2024
Язык: Английский
Процитировано
0